Perspectives on artificial intelligence in fertility care by healthcare professionals and patients:
a cross-sectional study
This study is sponsored by Future Fertility and Ferring Pharmaceuticals Canada.
STUDY ID: FF-FE SP-009-2023
SURVEY OBJECTIVE:
The primary aim of this survey is to assess the attitudes and perceptions of patients in Canada undergoing IVF and egg freezing, as well as healthcare professionals, including embryologists and clinicians, regarding the use of artificial intelligence in fertility care. Additionally, the survey seeks to identify both the advantages and barriers associated with the adoption of this technology.
WHO IS ELIGIBLE TO PARTICIPATE?
We invite Canadian residents who are one of the following:
- • IVF or Egg Freezing patients having received treatment within the past 2 years
- • Fertility specialists
- • Embryologists
For each survey completion by an eligible participant, Future Fertility will donate $30 to Fertility Friends Foundation, to a maximum of $5000, to help fund fertility grants to break down the financial barriers to parenthood.
To learn more about the wonderful work Fertility Friends Foundation is doing, visit fertilityfriendsfoundation.com.
This study has been reviewed and received ethics clearance through Veritas IRB (Veritas ID #3499).
If you have any questions related to this study, please contact the Future Fertility research team at marketresearch@futurefertility.com.
